Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group.

After federal health officials made abrupt changes to US Covid-19 vaccine recommendations for pregnant women last month, there’s new confusion and uncertainty about who can get the shots — and some reports that patients were turned away when they tried to get vaccinated.

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults below the age of 50 who are at risk of the disease, the British drugmaker said on Friday.

Just two days after retiring the entirety of the US Centers for Disease Control and Prevention’s vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government’s Covid-19 response to that committee.

FILE PHOTO: U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. testifies before a Senate Health, Education, Labor & Pensions Committee hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 14, 2025. REUTERS/Leah Millis/File Photo

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck’s Gardasil vaccine, court records show.

A new vaccine against gonorrhoea will be rolled out in Scotland in August following a UK-wide rise in cases. The illness, which is the second most common sexually transmitted infection (STI) in Scotland is potentially painful and in rare cases can be life-threatening.